#Viral
A new approach to fighting rheumatoid arthritis (cimzia.com)
Posted on: June 10, 2009 user submitted | Views: | Comment
UCB offers Cimzia® (certolizumab pegol), a treatment option for adults with moderately to severely active rheumatoid arthritis and moderate to severe Crohn's disease, to U.S. patients in an exclusively designed prefilled syringe resulting from the UCB partnership with OXO®.
To view Multimedia News Release, go to http://www.prnewswire.com/mnr/cimzia/35009/
